Targeted tumor coating with antigenic, CTL-recognizable peptides via Annexin A5 chimeric constructs following chemotherapy redirects adaptive CD8+T cell immunity for tumor clearance
Open Access
- 1 June 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Cellular & Molecular Immunology
- Vol. 18 (6), 1578-1580
- https://doi.org/10.1038/s41423-020-00563-x
Abstract
No abstract availableFunding Information
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50 CA098252, R21CA234516, R01 CA233486, P50 CA098252, R21CA234516, R01 CA233486, P50 CA098252, R21CA234516, R01 CA233486)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- Konkuk University (KU Research Professor Program)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
This publication has 8 references indexed in Scilit:
- Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future DirectionsFrontiers in Immunology, 2020
- Antibody-mediated delivery of viral epitopes to tumors harnesses CMV-specific T cells for cancer therapyNature Biotechnology, 2020
- Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatmentNature Communications, 2020
- Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptideCell & Bioscience, 2013
- Targeted Coating With Antigenic Peptide Renders Tumor Cells Susceptible to CD8+ T Cell-mediated KillingMolecular Therapy, 2013
- The determinants of tumour immunogenicityNature Reviews Cancer, 2012
- A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assaysJournal of Immunological Methods, 2001
- A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin VJournal of Immunological Methods, 1995